B-NDG hB2M/HLA-A3.1 mice

NOD.CB17-PrkdcscidIl2rgtm1BcgenB2mtm1(B2M/HLA-A3.1)Bcgen/Bcgen • 112450

商品を注文する

B-NDG hB2M/HLA-A3.1 mice

Product nameB-NDG hB2M/HLA-A3.1 mice
Catalog number112450
Strain nameNOD.CB17-PrkdcscidIl2rgtm1BcgenB2mtm1(B2M/HLA-A3.1)Bcgen/Bcgen
Strain backgroundB-NDG
NCBI gene ID3105,3561,5591,567 (Human)
AliasesCD132; CIDX; IL-2RG; IMD4; P64; SCIDX; SCIDX1; DNA-PKC; DNA-PKcs; DNAPK; DNAPKc; DNPK1; HYRC; HYRC1; IMD26; XRCC7; p350; HLAA; IMD43; p350; CD132; SCIDX1; IMD43; HLAA
ApplicationTo verify the efficacy of HLA-A3.1 restricted vaccines and antibody-based therapies；Promote the development of human CD8+ T cells
商品を注文する

このページで

  • Phenotypic analysis

ポスター

すべて表示

    出版物

      Protein expression analysis
      B2M and HLA-A3.1 expression analysis in homozygous B-NDG hB2M/HLA-A3.1 mice by flow cytometry. Splenocytes were collected from B-NDG mice (+/+) and homozygous B-NDG hB2M/HLA-A3.1 mice (H/H), and analyzed by flow cytometry with strain specific antibodies. Mouse B2M was detectable in B-NDG mice but not in B-NDG hB2M/HLA-A3.1 mice. Human B2M and HLA-A3 were exclusively detectable in homozygous B-NDG hB2M/HLA-A3.1 mice but not in B-NDG mice.
      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-NDG hB2M/HLA-A3.1 mice] (Cat# 112450) was purchased from Biocytogen.